Sign in

CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
813909017
Phone
(510) 871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
Open-market buys, last 90 days
$23,401
in 1 filing
Open-market sales, last 90 days
$5,107
in 3 filings

Net +$18,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-06-06 Noonberg Sarah B. Chief Medical Officer Sale −5,239 $1.75 $9K 109,135
2025-06-06 Wapnick Pamela Chief Financial Officer Sale −1,576 $1.75 $3K 72,108
2025-06-06 Thomas Brian C. Chief Executive Officer Sale −10,785 $1.75 $19K 2,517,491
2025-06-06 Irish Jian See Remarks Sale −6,390 $1.75 $11K 315,543
2025-04-01 Wapnick Pamela Chief Financial Officer Grant or award +14,000 73,684
2025-04-01 Wapnick Pamela Chief Financial Officer Grant or award · Stock Option (Right to Buy) +84,000 84,000
2025-04-01 Thomas Brian C. Chief Executive Officer Grant or award +32,000 2,528,276
2025-04-01 Thomas Brian C. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +196,000 196,000
2025-04-01 Irish Jian See Remarks Grant or award +23,000 321,933
2025-04-01 Irish Jian See Remarks Grant or award · Stock Option (Right to Buy) +140,000 140,000
2025-04-01 Wein Matthew See Remarks Grant or award +3,650 13,117
2025-04-01 Wein Matthew See Remarks Grant or award +3,775 16,892
2025-04-01 Wein Matthew See Remarks Grant or award · Stock Option (Right to Buy) +21,875 21,875
2025-04-01 Wein Matthew See Remarks Grant or award · Stock Option (Right to Buy) +22,725 22,725
2025-04-01 Noonberg Sarah B. Chief Medical Officer Grant or award +14,000 114,374
2025-04-01 Noonberg Sarah B. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +84,000 84,000
2025-03-05 Wein Matthew See Remarks Sale −930 $1.87 $2K 9,467
2025-03-05 Wapnick Pamela Chief Financial Officer Sale −1,808 $1.87 $3K 59,684
2025-02-03 BJERKHOLT ERIC Director Grant or award · Stock Option (Right to Buy) +42,000 42,000
2024-12-05 Wapnick Pamela Chief Financial Officer Sale −1,559 $1.86 $3K 61,492

Page 3 of 6 · 101 trades